Shanghai Qilu Pharmaceutical Research and Development Center LTD
3 clinical trials · Sponsor
◉ Watch Shanghai Qilu Pharmaceutical Research and Development Center LTD
| Record | Firm | Date |
|---|---|---|
| Phase I Study of QLS1510 Tablets in Healthy Participants (NCT07760077) | Shanghai Qilu Pharmaceutical Research and Development Center LTD | 2026-08-30 |
| This Study Aims to Evaluate the Efficacy and Safety of QLS1317 in Patients With MSI-H/dMMR Advanced Solid Tumors. (NCT07552376) | Shanghai Qilu Pharmaceutical Research and Development Center LTD | 2026-05-01 |
| A Phase I Study of QLS12010 Capsules: Safety, Tolerability, PK, PD, and Food Effects in Healthy Adults and Moderate to Severe Atopic Dermatitis Patients (NCT06946641) | Shanghai Qilu Pharmaceutical Research and Development Center LTD | 2025-03-31 |
Track Shanghai Qilu Pharmaceutical Research and Development Center LTD automatically
Every clearance here is in the API, with alerts when new ones post.